Abstracts pas de poussée de psorisis (12%)-no answers (4%)-Psoriasis had a greater adverse affect on patients with crise: PDI score = 20.24 (sd 17.52) than the patient without actual crise PDI score = 8.98 (sd 11.34). This difference was significative p < 0.00001. CONCLUSION: These results highlight the value of appropriate and relevant psychological and medical environment for patients suffering from psoriasis. 
OBJECTIVES:
Melasma, a facial pigmentary condition affecting women, can have significant emotional and psychological effects on those affected. Our purpose was to develop and validate a disease-specific HRQoL instrument to identify the areas of the patient's life most impaired by melasma as well as the effects of the condition on their level of functioning in correlation with disease severity, the Melasma Quality of Life scale (MELASQOL). METHODS: A random sample of 102 women identified by an investigator as having melasma were evaluated by the investigator using the Melasma Area and Severity Index (MASI). The patients were then anonymously surveyed with the SKINDEX-16, the Fear of Negative Evaluation scale, the Dermatology Life Quality Index (DLQI), a specially-developed skin discoloration evaluation questionnaire, and a measure of perceived life quality difference without melasma. The 10-item MELASQOL scale was devised from the comprehensive HRQoL assessment battery. RESULTS: The psychometric properties of the MELASQOL were comparable with the properties of the DLQI and the SKINDEX-16. The MELASQOL scores were highly correlated with the other HRQoL measures. The discriminatory ability of the MELASQOL is superior to the SKINDEX-16 and the DLQI for melasma. The three life domains most adversely affected by melasma (social life, recreation/leisure, and emotional well-being) were highlighted by this instrument. These were the same three areas of life that patients believed would improve the most if they no longer were affected by the disease. CON-CLUSION: The MELASQOL can be used to objectively evaluate the effect of melasma on a patient's HRQoL. The high correlation with the DLQI, the SKINDEX-16, and the skin discoloration questionnaire suggests that the new scale is a valid instrument, which can be used to monitor the level of impairment individuals suffer due to their melasma. 
GASTROINTESTINAL DISEASES/DISORDERS-

OBJECTIVE:
To examine the effect of mail-based interventions on appropriate prescribing of COX-2 inhibitors for patients at increased risk for adverse gastrointestinal (GI) events. METHODS: The 600 highest-volume prescribers of COX-2 inhibitors were identified from a health plan database from October to December 2001, and randomly assigned to one of three intervention groups: 1) High intervention (profile incorporating probability of GI bleed); 2) Medium intervention (pharmacy claim information only; no probability modeling); and 3) No intervention. Intervention physicians received monthly profiles for 6 months (May 2002 through October 2002). Risk factors used to calculate the probability of GI bleed included: history of ulcer, arthritis, GI bleed, concurrent use of anticoagulants or oral steroids, and age greater than 65 years. Appropriate usage metrics were changes in mean proportion of patients with each risk factor and percentage of COX-2 inhibitor prescriptions out of all anti-inflammatory medications. Proportions were compared between intervention groups. Statistical analyses were performed using multivariate Generalized Estimating Equations (GEE). RESULTS: Baseline proportions of COX-2 prescriptions for high intervention, medium intervention, and no intervention groups were 0.602 ± 0.192, 0.603 ± 0.202, and 0.589 ± 0.202, respectively; 5-month post-intervention proportions were 0.587 ± 0.269, 0.588 ± 0.253, and 0.619 ± 0.255, respectively; adjusted GEE coefficients were -0.048 (p = 0.001), -0.044 (p = 0.002), for the high and medium intervention groups, respectively. Proportion of patients with a history of ulcer, GI bleed, and arthritis also increased by 33%, 41%, and 26%, respectively, across all groups. However, differences between groups were not significant. CONCLUSIONS: Preliminary analysis has shown a positive change in prescribing patterns. First, there was a decrease in the proportion of patients receiving COX-2 inhibitors. Second, in patients receiving COX-2 inhibitors, the proportion of patients with select risk factors (history of ulcer, GI bleed, and arthritis) increased.
